Strategies to eliminate cervical cancer in China

被引:22
作者
Ji, Lu [1 ]
Chen, Manli [2 ]
Yao, Lan [1 ]
机构
[1] Huazhong Univ Sci & Technol, Sch Med & Hlth Management, Tongji Med Coll, Wuhan, Peoples R China
[2] Hubei Univ Chinese Med, Sch Management, Wuhan, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词
cervical cancer; HPV vaccination; cervical cancer screening; eliminate cervical cancer; strategies; HUMAN-PAPILLOMAVIRUS VACCINE; COMPARATIVE MODELING ANALYSIS; 78; LOW-INCOME; HPV VACCINATION; INTRAEPITHELIAL NEOPLASIA; ARTIFICIAL-INTELLIGENCE; COST-EFFECTIVENESS; PREVENTION; IMPACT; INFECTION;
D O I
10.3389/fonc.2023.1105468
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cervical cancer is a widely distributed disease that is preventable and controllable through early intervention. The World Health Organization has identified three key measures, coverage populations and coverage targets to eliminate cervical cancer. The WHO and several countries have conducted model predictions to determine the optimal strategy and timing of cervical cancer elimination. However, specific implementation strategies need to be developed in the context of local conditions. China has a relatively high disease burden of cervical cancer but a low human papillomavirus vaccination rate and cervical cancer screening population coverage. The purpose of this paper is to review interventions and prediction studies for the elimination of cervical cancer and to analyze the problems, challenges and strategies for the elimination of cervical cancer in China.
引用
收藏
页数:10
相关论文
共 106 条
  • [1] [Anonymous], GENEVA ASSESSING NAT
  • [2] [Anonymous], GENEVA GLOBAL STRATE
  • [3] [Anonymous], CANC FACTS FIGURES 2
  • [4] [Anonymous], National Health Commission of the PRC Homepage lt
  • [5] [Anonymous], WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, Vsecond
  • [6] [Anonymous], Recommendations to assure the quality, safety and efficacy of pneumococcal conjugate vaccines, Annex 3, TRS No 977
  • [7] Age-specific effectiveness of primary human papillomavirus screening versus cytology in a cervical cancer screening program: a nationwide cross-sectional study
    Bao, Heling
    Ma, Lan
    Zhao, Yanxia
    Song, Bo
    Di, Jiangli
    Wang, Linhong
    Gao, Yanqiu
    Ren, Wenhui
    Wang, Shi
    Wu, Jiuling
    Wang, Hai-Jun
    [J]. CANCER COMMUNICATIONS, 2022, 42 (03) : 191 - 204
  • [8] Artificial intelligence-assisted cytology for detection of cervical intraepithelial neoplasia or invasive cancer: A multicenter, clinical-based, observational study
    Bao, Heling
    Bi, Hui
    Zhang, Xiaosong
    Zhao, Yun
    Dong, Yan
    Luo, Xiping
    Zhou, Deping
    You, Zhixue
    Wu, Yinglan
    Liu, Zhaoyang
    Zhang, Yuping
    Liu, Juan
    Fang, Liwen
    Wang, Linhong
    [J]. GYNECOLOGIC ONCOLOGY, 2020, 159 (01) : 171 - 178
  • [9] The artificial intelligence-assisted cytology diagnostic system in large-scale cervical cancer screening: A population-based cohort study of 0.7 million women
    Bao, Heling
    Sun, Xiaorong
    Zhang, Yi
    Pang, Baochuan
    Li, Hua
    Zhou, Liang
    Wu, Fengpin
    Cao, Dehua
    Wang, Jian
    Turic, Bojana
    Wang, Linhong
    [J]. CANCER MEDICINE, 2020, 9 (18): : 6896 - 6906
  • [10] Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study
    Basu, Partha
    Malvi, Sylla G.
    Joshi, Smita
    Bhatla, Neerja
    Muwonge, Richard
    Lucas, Eric
    Verma, Yogesh
    Esmy, Pulikkottil O.
    Poli, Usha Rani Reddy
    Shah, Anand
    Zomawia, Eric
    Pimple, Sharmila
    Jayant, Kasturi
    Hingmire, Sanjay
    Chiwate, Aruna
    Divate, Uma
    Vashist, Shachi
    Mishra, Gauravi
    Jadhav, Radhika
    Siddiqi, Maqsood
    Sankaran, Subha
    Prabhu, Priya Ramesh
    Kannan, Thiraviam Pillai Rameshwari Ammal
    Varghese, Rintu
    Shastri, Surendra S.
    Anantharaman, Devasena
    Gheit, Tarik
    Tommasino, Massimo
    Sauvaget, Catherine
    Pillai, M. Radhakrishna
    Sankaranarayanan, Rengaswamy
    [J]. LANCET ONCOLOGY, 2021, 22 (11) : 1518 - 1529